Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00171249
What this trial is testing

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

Who this might be right for
Philadelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Novartis Pharmaceuticals 293
Testing effectiveness (Phase 2)Study completedNCT00671658
What this trial is testing

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 220
Not applicableLooking for participantsNCT06367725
What this trial is testing

Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density

Who this might be right for
Acute Lymphoblastic Leukemia
University of Aarhus 100
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Not applicableApproved For MarketingNCT04943952
What this trial is testing

JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals
Not applicableEnrolling By InvitationNCT06795126
What this trial is testing

Little NIRVANA for Pediatric Pain and Anxiety

Who this might be right for
Acute PainProcedural AnxietyPediatric ALL+2 more
Nationwide Children's Hospital 130
Testing effectiveness (Phase 2)WithdrawnNCT01677949
What this trial is testing

Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Ended earlyNCT00949117
What this trial is testing

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

Who this might be right for
LeukemiaLymphomaMalnutrition+3 more
University of South Florida 9
Testing effectiveness (Phase 2)Study completedNCT03455140
What this trial is testing

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)

Who this might be right for
CancerPediatric Solid TumorPediatric AML+1 more
University of Birmingham 49
Early research (Phase 1)UnknownNCT00562068
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Cancer Research UK 30
Not applicableUnknownNCT04488237
What this trial is testing

Vitamin D and Methotrexate Adverse Effects

Who this might be right for
Acute Lymphoblastic Leukemia
Assiut University 50
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Testing effectiveness (Phase 2)Looking for participantsNCT07564453
What this trial is testing

Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
The First Affiliated Hospital of Soochow University 101
Not applicableLooking for participantsNCT06389305
What this trial is testing

CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia
Beijing GoBroad Hospital 213
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Early research (Phase 1)Study completedNCT02264873
What this trial is testing

Phase I, Dose Escalation Study of Decitabine

Who this might be right for
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
University of Florida 3
Large-scale testing (Phase 3)Study completedNCT00450450
What this trial is testing

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+7 more
Children's Oncology Group 27
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Early research (Phase 1)Ended earlyNCT00618696
What this trial is testing

Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 4
Early research (Phase 1)Not Yet RecruitingNCT07043218
What this trial is testing

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Shanghai Tongji Hospital, Tongji University School of Medicine 36
Next Page